Header cover image

Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis

UpdatedApr 30, 2024
DataAggregated Company Financials
Companies15
  • 7D1.0%
  • 3M-5.4%
  • 1Y-34.8%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 2.9%, with Shin Nippon Biomedical Laboratories up 5.6%. In contrast, the industry has lost 34% in the last 12 months. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 Apr 2024JP¥180.4bJP¥62.3bJP¥3.3b14.1x54.8x2.9x
Thu, 28 Mar 2024JP¥234.1bJP¥155.4bJP¥8.6b14.2x27.2x1.5x
Sat, 24 Feb 2024JP¥231.3bJP¥155.3bJP¥8.7b14.7x26.6x1.5x
Mon, 22 Jan 2024JP¥224.2bJP¥167.1bJP¥8.5b15.2x26.4x1.3x
Wed, 20 Dec 2023JP¥224.9bJP¥167.1bJP¥8.5b14.9x26.5x1.3x
Fri, 17 Nov 2023JP¥231.6bJP¥168.1bJP¥9.1b14.7x25.4x1.4x
Sun, 15 Oct 2023JP¥232.4bJP¥179.3bJP¥12.8b14.6x18.2x1.3x
Tue, 12 Sep 2023JP¥261.6bJP¥179.3bJP¥12.8b16.1x20.5x1.5x
Thu, 10 Aug 2023JP¥276.7bJP¥179.9bJP¥13.8b17.8x20x1.5x
Sat, 08 Jul 2023JP¥280.9bJP¥178.5bJP¥16.2b17.1x17.3x1.6x
Mon, 05 Jun 2023JP¥290.0bJP¥178.3bJP¥16.2b17x17.9x1.6x
Wed, 03 May 2023JP¥291.0bJP¥174.9bJP¥16.5b16.6x17.7x1.7x
Fri, 31 Mar 2023JP¥307.5bJP¥171.9bJP¥13.3b16.9x23.1x1.8x
Sun, 26 Feb 2023JP¥315.1bJP¥171.6bJP¥13.2b17.3x23.8x1.8x
Tue, 24 Jan 2023JP¥289.4bJP¥166.1bJP¥16.2b15.2x17.9x1.7x
Thu, 22 Dec 2022JP¥291.2bJP¥166.1bJP¥16.2b15.4x18x1.8x
Sat, 19 Nov 2022JP¥318.4bJP¥165.5bJP¥16.0b15.5x19.9x1.9x
Mon, 17 Oct 2022JP¥317.9bJP¥160.1bJP¥12.4b16.4x25.7x2x
Wed, 14 Sep 2022JP¥348.7bJP¥159.7bJP¥12.3b19.1x28.5x2.2x
Fri, 12 Aug 2022JP¥311.9bJP¥160.1bJP¥12.8b19.4x24.3x1.9x
Sun, 10 Jul 2022JP¥278.3bJP¥152.8bJP¥10.9b17.5x25.6x1.8x
Tue, 07 Jun 2022JP¥267.5bJP¥152.7bJP¥10.9b18.2x24.6x1.8x
Thu, 05 May 2022JP¥245.7bJP¥152.3bJP¥11.4b20.3x21.6x1.6x
Sat, 02 Apr 2022JP¥249.4bJP¥144.9bJP¥10.6b21.7x23.5x1.7x
Mon, 28 Feb 2022JP¥230.3bJP¥144.7bJP¥10.5b18.8x21.9x1.6x
Wed, 26 Jan 2022JP¥232.4bJP¥136.0bJP¥6.8b19.5x34.4x1.7x
Fri, 24 Dec 2021JP¥282.5bJP¥136.0bJP¥6.8b23.6x41.9x2.1x
Sun, 21 Nov 2021JP¥349.8bJP¥135.7bJP¥6.9b28.1x50.8x2.6x
Tue, 19 Oct 2021JP¥371.8bJP¥198.7bJP¥8.1b25.9x46.1x1.9x
Thu, 16 Sep 2021JP¥378.1bJP¥202.2bJP¥5.2b25.6x73.2x1.9x
Sat, 14 Aug 2021JP¥355.8bJP¥201.8bJP¥5.0b25.9x70.6x1.8x
Wed, 09 Jun 2021JP¥321.0bJP¥194.0bJP¥2.5b29.5x130.5x1.7x
Price to Earnings Ratio

122.2x


Total Market Cap: JP¥300.8bTotal Earnings: JP¥2.5bTotal Revenue: JP¥194.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Clinical Research and Equipment Industry Price to Earnings3Y Average 33x202220232024
Current Industry PE
  • Investors are optimistic on the Japanese Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 54.8x which is higher than its 3-year average PE of 35.4x.
  • The 3-year average PS ratio of 1.7x is lower than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 10% per year over the last three years.
  • Meanwhile revenues for these companies have declined 32% per year.
  • This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.

Industry Comparison

How does Japanese Clinical Research and Equipment compare with similar industries?

JP Market0.80%
Healthcare1.10%
Life Sciences1.05%
Clinical Research and Equipment1.05%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2395 Shin Nippon Biomedical LaboratoriesJP¥1.54k6.5%
+JP¥3.9b
-38.8%PE11.7x
4880 CellSourceJP¥1.56k2.6%
+JP¥772.4m
-38.0%PE36.3x
2397 DNA Chip ResearchJP¥1.08k5.3%
+JP¥365.4m
73.4%PS16.9x
130A Veritas In SilicoJP¥1.73k2.2%
+JP¥242.0m
n/an/a
2183 LinicalJP¥403.001.3%
+JP¥112.9m
-42.5%PE13.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2183

JP¥403.00

Linical

7D

1.3%

1Y

-42.5%

2309

JP¥2,644.00

CMIC HOLDINGS

7D

0.2%

1Y

26.6%

2397

JP¥1,075.00

DNA Chip Research

7D

5.3%

1Y

73.4%

4892

JP¥706.00

Cyfuse Biomedical K.K

7D

0.6%

1Y

-47.8%

2395

JP¥1,542.00

Shin Nippon Biomedical Laboratories

7D

6.5%

1Y

-38.8%

7079

JP¥4,500.00

WDB coco

7D

-1.7%

1Y

-3.6%

4880

JP¥1,559.00

CellSource

7D

2.6%

1Y

-38.0%

4570

JP¥470.00

Immuno-Biological Laboratories

7D

2.0%

1Y

27.4%

7707

JP¥200.00

Precision System Science

7D

-0.5%

1Y

-45.4%

4583

JP¥124.00

Chiome Bioscience

7D

-3.1%

1Y

-36.1%

130A

JP¥1,731.00

Veritas In Silico

7D

2.2%

1Y

n/a

2370

JP¥45.00

MEDINET

7D

-2.2%

1Y

-31.8%